Heat production during anesthetic-induced malignant hyperthermia

Bioscience Reports

Volumn 21, Issue 2, 2001, Pages 169-179

  Nelson, T E ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Anesthetics; Calcium; Malignant hyperthermia; Oxygen consumption; Ryanodine receptor mutations; Skeletal muscle

Indexed keywords

CALCIUM ION; INHALATION ANESTHETIC AGENT; MUSCLE RELAXANT AGENT; NEUROMUSCULAR DEPOLARIZING AGENT; RYANODINE RECEPTOR;

CALCIUM CELL LEVEL; CALCIUM TRANSPORT; GENE MUTATION; GENETIC PREDISPOSITION; HUMAN; HYPERMETABOLISM; MALIGNANT HYPERTHERMIA; MUSCLE FIBRIL; NONHUMAN; OXYGEN CONSUMPTION; PHARMACOGENETICS; SARCOPLASMIC RETICULUM; SHORT SURVEY; THERMOGENESIS;

ANESTHESIA, GENERAL; ANIMALS; CALCIUM; HUMANS; MALIGNANT HYPERTHERMIA; MODELS, BIOLOGICAL; MUSCLE, SKELETAL; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; THERMOGENESIS;

EID: 0035161109     PISSN: 01448463     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1013696124358     Document Type: Short Survey

References (35)

1. Anesthetic deaths in a family
2. Central and peripheral mechanisms in malignant hyperthermia
3. Disturbances of the oxidativephosphorylation mechanism as a possible etiological factor in sudden unexplained hyperthermia occurring during anesthesia
4. In vivo induced malignant hyperthermia in pigs. II. Metabolism of skeletal muscle mitochondria
5. Metabolic error of muscle metabolism after recovery from malignant hyperthermia
6. Halothane-induced muscle contracture as a cause of hyperpyrexia
7. Identification of susceptibility to malignant hyperpyrexia
8. A protocol for the investigation of malignant hyperpyrexia (MH) susceptibility
9. Standardization of the caffeine halothane muscle contracture test
10. Malignant hyperthermia of swine
11. Porcine stress syndromes
12. Porcine malignant hyperthermia: Observations on the occurrence of pale, soft, exudative musculature among susceptible pigs
13. Dantrolene dose response in malignant hyperthermia-susceptible (MHS) swine: Method to obtain prophylaxis and therapeusis
14. Dantrolene dose response in awake man: Implications for management of malignant hyperthermia
15. Malignant hyperthermia in dogs
16. Malignant hyperthermia in the cat
17. Malignant hyperthermia in a halothane-anesthetized horse
18. Pharmacogenetics and malignant hyperthermia
19. Cellular membrane potentials and contractile threshold in mammalian skeletal muscle susceptible to malignant hyperthermia
20. The mechanism of induction of malignant hyperpyrexia based on in vitro to in vivo correlative studies
21. Skeletal muscle sarcoplasmic reticulum in the malignant hyperthermia syndrome
22. Abnormality in calcium release from skeletal sarcoplasmic reticulum of pigs susceptible to malignant hyperthermia
23. Dantrolene in human malignant hyperthermia
24. Purification and reconstitution of the calcium release channel from skeletal muscle
25. Identification of a mutation in porcine ryanodine receptor associated with malignant hyperthermia
26. Identification of novel mutations in the ryanodine-receptor gene (RyR1) in malignant hyperthermia: Genotype-phenotype correlation
27. Ryanodine receptor gene is a candidate for predisposition to malignant hyperthermia
28. Malignant-hyperthermia susceptibility is associated with a mutation of the alpha 1-subunit of the human dihydropyridine-sensitive L-type voltage-dependent calcium-channel receptor in skeletal muscle
29. Genetics and pathogenesis of malignant hyperthermia
30. Dantrolene sodium can increase or attenuate activity of skeletal muscle ryanodine receptor calcium release channel. Clinical implications
31. 2+-ATPase and ryanodine receptor in cold-acclimated ducklings and thermogenesis
32. 2+-dependent heat production under basal and near-basal conditions in the mouse soleus muscle
33. Thermogenesis in muscle
34. Porcine malignant hyperthermia: Critical temperatures for in vivo and in vitro responses